24.11

3.56% -0.89

Pre-market: 24.46 0.35 +1.45%

Vor Biopharma Inc (VOR)

Overview News Price History Option Chain Financials Discussions Forecast

Vor Biopharma Inc stock is traded at $24.11, with a volume of 222.50K. It is down -3.56% in the last 24 hours and down -50.51% over the past month. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Previous Close:

$25.00

Open:

$25.22

24h Volume:

222.50K

Relative Volume:

0.64

Market Cap:

$171.35M

Revenue:

Net Income/Loss:

$-112.46M

P/E Ratio:

-14.70

EPS:

-1.64

Net Cash Flow:

$-99.89M

1W Performance:

-11.33%

1M Performance:

-50.51%

6M Performance:

+77.51%

1Y Performance:

+43.55%

1-Day Range:

$24.05

$26.76

1-Week Range:

$23.12

$28.66

52-Week Range:

$2.622

$65.80

Vor Biopharma Inc Stock (VOR) Company Profile

Name

Vor Biopharma Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

617-655-6580

Address

100 CAMBRIDGEPARK DRIVE, CAMBRIDGE

Employee

168

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

VOR's Discussions on Twitter

Compare VOR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VOR Vor Biopharma Inc	24.11	171.35M	0	-112.46M	-99.89M	-1.64
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-15-25	Upgrade	Robert W. Baird	Neutral → Outperform
Sep-24-25	Upgrade	Stifel	Hold → Buy
Jun-30-25	Upgrade	H.C. Wainwright	Neutral → Buy
Jul-26-22	Initiated	Wedbush	Outperform
Apr-27-22	Initiated	Goldman	Neutral
Dec-17-21	Initiated	H.C. Wainwright	Buy
Dec-03-21	Initiated	Robert W. Baird	Outperform
Dec-02-21	Initiated	Oppenheimer	Outperform
Oct-19-21	Initiated	JMP Securities	Mkt Outperform
Mar-25-21	Initiated	B. Riley Securities	Buy
Mar-03-21	Initiated	Barclays	Overweight
Mar-03-21	Initiated	Evercore ISI	Outperform
Mar-02-21	Initiated	Goldman	Sell
Mar-02-21	Initiated	Stifel	Buy

View All

Vor Biopharma Inc Stock (VOR) Latest News

04:21 AM

Technical signs of recovery in Vor Biopharma Inc.July 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com

04:21 AM

02:43 AM

Vor Biopharma Inc. stock volume spike explainedVolume Spike & Community Trade Idea Sharing - newser.com

02:43 AM

02:33 AM

Will Vor Biopharma Inc. stock gain from government policiesQuarterly Profit Report & Real-Time Stock Movement Alerts - newser.com

02:33 AM

Nov 02, 2025

Long term hold vs stop loss in Vor Biopharma Inc.Weekly Trend Recap & Fast Entry Momentum Alerts - newser.com

Nov 02, 2025

Vor Biopharma Inc. stock retracement – recovery analysisMarket Trend Summary & Verified Swing Trading Watchlists - newser.com

Nov 02, 2025

Applying big data sentiment scoring on Vor Biopharma Inc.Day Trade & Weekly Market Pulse Updates - newser.com

Nov 02, 2025

Vor Biopharma Inc. stock chart pattern explainedJuly 2025 Technicals & Verified Swing Trading Watchlists - newser.com

Nov 02, 2025

Risk adjusted return profile for Vor Biopharma Inc. analyzedNew Guidance & Long-Term Safe Investment Plans - newser.com

Nov 02, 2025

How currency fluctuations impact Vor Biopharma Inc. stockWeekly Investment Recap & Smart Money Movement Tracker - newser.com

Nov 02, 2025

Using data models to predict Vor Biopharma Inc. stock movementWeekly Risk Report & Weekly Stock Performance Updates - newser.com

Nov 02, 2025

Pattern recognition hints at Vor Biopharma Inc. upsideQuarterly Portfolio Report & Long-Term Safe Return Strategies - newser.com

Nov 02, 2025

Published on: 2025-11-02 01:05:22 - newser.com

Nov 02, 2025

Nov 01, 2025

Q3 EPS Estimates for Vor Biopharma Boosted by HC Wainwright - MarketBeat

Nov 01, 2025

Combining price and volume data for Vor Biopharma Inc.Weekly Loss Report & Weekly Watchlist of Top Performers - newser.com

Nov 01, 2025

Oct 31, 2025

Can Vor Biopharma Inc. stock resist sector downturnsCPI Data & Daily Profit Maximizing Tips - newser.com

Oct 31, 2025

Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 124,311 Shares - MarketBeat

Oct 31, 2025

Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 251,518 Shares - MarketBeat

Oct 31, 2025

RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Vor Biopharma Inc. - GuruFocus

Oct 31, 2025

Vor Bio (NASDAQ: VOR) issues inducement equity to 20 new hires at $30.22 per share - Stock Titan

Oct 31, 2025

FY2028 EPS Estimates for Vor Biopharma Decreased by Analyst - MarketBeat

Oct 31, 2025

Published on: 2025-10-31 05:21:03 - newser.com

Oct 31, 2025

Oct 30, 2025

Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million By Investing.com - Investing.com Nigeria

Oct 30, 2025

Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million - Investing.com

Oct 30, 2025

VOR Form 4: RA Capital reports multi-day insider stock sales - Stock Titan

Oct 30, 2025